Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Nov 16, 2021

SELL
$30.02 - $39.87 $4.36 Million - $5.79 Million
-145,300 Reduced 87.42%
20,900 $710,000
Q2 2021

Aug 16, 2021

BUY
$32.22 - $44.59 $173,988 - $240,786
5,400 Added 3.36%
166,200 $6.79 Million
Q1 2021

May 18, 2021

BUY
$37.26 - $67.74 $2.64 Million - $4.8 Million
70,900 Added 78.87%
160,800 $6.47 Million
Q4 2020

Feb 17, 2021

BUY
$45.01 - $65.47 $1.49 Million - $2.16 Million
33,000 Added 58.0%
89,900 $5.32 Million
Q3 2020

Nov 17, 2020

BUY
$35.79 - $48.81 $132,423 - $180,597
3,700 Added 6.95%
56,900 $2.77 Million
Q2 2020

Aug 17, 2020

BUY
$24.95 - $48.38 $1.33 Million - $2.57 Million
53,200 New
53,200 $2.57 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $1.11B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.